CNO Financial Group (CNO) Earnings Date & Reports

Key Takeaways

• CNO Financial Group reported third-quarter 2026 net income of $161.1 million, or $1.71 per diluted share, up sharply from $23.1 million, or $0.24 per share, in the prior-year quarter.
• Net operating income, a non-GAAP measure, came in at $179.1 million, or $1.90 per diluted share, up roughly 47% year over year.
• Total revenue of about $1.09 billion exceeded the consensus estimate near $1.01 billion, even as it declined from $1.19 billion a year earlier.
• Management raised its full-year 2026 operating earnings per share (EPS) guidance, lifting the midpoint to about 9% above its prior outlook.
• The quarter marked a 17th consecutive quarter of sales growth, and the company repurchased $60 million of common stock.
• For additional detail, explore CNO's Major News, Today's Price Move, Price Targets, and Forecast pages.
• Discover AI-powered trading strategies and ideas by exploring Trending AI Robots.

Earnings Context and Why It Matters

CNO Financial Group is a leading provider of life and health insurance and retirement products focused on middle-income Americans. Its quarterly results offer investors a direct read on underwriting discipline, sales momentum, and capital management. The third-quarter release carried extra weight because the company was coming off a prior-year period that included a large goodwill impairment charge, making year-over-year profit comparisons particularly favorable. Beyond the headline numbers, investors were watching whether CNO could extend its long run of sales growth, improve operating profitability, and deploy capital efficiently through buybacks and reinsurance. The results also provided an early signal on how rising interest rates continue to affect the company's book value and fixed indexed annuity liabilities.

Reported Results

For the third quarter ended September 30, 2026, CNO reported net income of $161.1 million, or $1.71 per diluted share, compared with $23.1 million, or $0.24 per diluted share, a year earlier. Net operating income, a non-GAAP (non-GAAP means a measure that excludes certain items not part of core operations) metric, was $179.1 million, or $1.90 per diluted share, up about 47% from the prior year.

Total revenue was approximately $1.09 billion, above the consensus estimate near $1.01 billion but down from $1.19 billion in the year-ago quarter. On an operating basis, EPS of $1.90 beat analyst expectations of roughly $1.10 by a wide margin. Significant items had a favorable impact of about $44.9 million on both net income and net operating income during the quarter.

Book value per common share was $25.34, down from $27.24 a year earlier, largely reflecting the effect of higher interest rates on the company's investment portfolio. The company's consolidated statutory risk-based capital ratio, a measure of an insurer's financial strength, was estimated at 374%.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities far more efficiently than manual screening. For investors following names like CNO Financial Group, it offers a practical way to surface comparable opportunities and monitor shifting technical and fundamental conditions across the insurance sector.

Market Reaction and Investor Sentiment

Investors responded positively to the report, with shares advancing in the immediate aftermath of the release, moving roughly 2% to around $56 per share according to early trading data. The stronger-than-expected operating EPS, which beat consensus by a substantial margin, and the upward revision to full-year guidance were the primary drivers of the favorable reaction. The reinsurance transaction covering approximately $270 million of Colonial Penn in-force graded benefit life statutory reserves also signaled progress on capital efficiency and risk management. Sentiment heading into the print had been constructive given CNO's track record of consistent sales growth, and the results reinforced that view by delivering both an earnings beat and a guidance increase.

Forward Outlook and Key Factors to Monitor

Following the earnings beat and guidance raise, investors will be watching whether CNO can sustain its operating momentum through the remainder of 2026 and into 2027. The company's raised full-year operating EPS guidance, with a midpoint about 9% above the prior level, sets a higher bar that will require continued disciplined execution and stable underwriting results.

Capital deployment remains a central theme. With about $240 million remaining under its share repurchase authorization and an active history of buybacks, further repurchase activity could support per-share metrics. At the same time, the company's third reinsurance transaction with its Bermuda affiliate highlights an ongoing effort to manage risk and free up capital, a strategy worth monitoring for its effect on statutory results and future earnings.

Interest-rate sensitivity is another key factor. Rising rates have pressured book value through accumulated other comprehensive losses on the company's fixed-income portfolio, even as they may improve future investment income. Investors should also track the technology modernization initiative, known as TechMod, which continues to generate expenses as it rolls out.

Finally, keep an eye on sales trends across CNO's core segments. The 17-quarter sales growth streak is a defining feature of the company's recent performance, and any change in that trajectory could influence how the market values the stock going forward.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations